These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3090927)

  • 21. Antitumor activity and hydrogen peroxide release by macrophages elicited by trehalose diesters.
    Lepoivre M; Tenu JP; Lemaire G; Petit JF
    J Immunol; 1982 Aug; 129(2):860-6. PubMed ID: 6806386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Massive apoptosis in P815 mastocytoma in vivo induced by interleukin 2 gene transduction].
    Guo N; Li X; Liu X
    Zhonghua Bing Li Xue Za Zhi; 1996 Oct; 25(5):284-7. PubMed ID: 9388873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytostatic effect of macrophages from non-immunised mice on mastocytoma P-815 cells in vitro.
    Bandlow G; Gröner R
    J Cancer Res Clin Oncol; 1979 Jul; 94(3):225-32. PubMed ID: 113416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The binding of BCG-activated macrophages to tumor targets stimulates secretion of cytolytic factor.
    Johnson WJ; Whisnant CC; Adams DO
    J Immunol; 1981 Nov; 127(5):1787-92. PubMed ID: 6795261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of altered B7 expression in dioxin immunotoxicity: B7 transfection restores the CTL but not the autoantibody response to the P815 mastocytoma.
    Prell RA; Kerkvliet NI
    J Immunol; 1997 Mar; 158(6):2695-703. PubMed ID: 9058803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement in accessibility to macrophages by modification of mucin-type carbohydrate chains on a tumor cell line: role of a C-type lectin of macrophages.
    Sakamaki T; Imai Y; Irimura T
    J Leukoc Biol; 1995 Mar; 57(3):407-14. PubMed ID: 7884311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The binding of tumor cells by murine mononuclear phagocytes can be divided into two qualitatively distinct types.
    Somers SD; Mastin JP; Adams DO
    J Immunol; 1983 Oct; 131(4):2086-93. PubMed ID: 6413586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Humoral mechanisms of in vitro inhibition of mouse lymphocyte immunoreactivity by mastocytoma P815 cells].
    Medvedev AE
    Biull Eksp Biol Med; 1988 Jun; 105(6):701-3. PubMed ID: 2968820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity.
    Celada A; Gray PW; Rinderknecht E; Schreiber RD
    J Exp Med; 1984 Jul; 160(1):55-74. PubMed ID: 6330272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple tumoricidal effector mechanisms induced by adriamycin.
    Salazar D; Cohen SA
    Cancer Res; 1984 Jun; 44(6):2561-6. PubMed ID: 6327018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The third component of complement (C3) bound to tumor target cells enhances their sensitivity to killing by activated macrophages.
    Bara S; Lint TF
    J Immunol; 1987 Feb; 138(4):1303-9. PubMed ID: 3100634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B cell lymphoma-2 transfected P815 cells resist reactive nitrogen intermediate-mediated macrophage-dependent cytotoxicity.
    Albina JE; Martin BA; Henry WL; Louis CA; Reichner JS
    J Immunol; 1996 Jul; 157(1):279-83. PubMed ID: 8683126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Further characterization of macrophage adsorption of suppressor cell activity from tumor-allosensitized spleen.
    Zografos-Miller LE; Argyris BF
    Transplantation; 1983 Jun; 35(6):593-600. PubMed ID: 6223418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice.
    Uyttenhove C; Van Snick J; Boon T
    J Exp Med; 1980 Nov; 152(5):1175-83. PubMed ID: 6776226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor cell surface expression of granulocyte-macrophage colony-stimulating factor elicits antitumor immunity and protects from tumor challenge in the P815 mouse mastocytoma tumor model.
    Soo Hoo W; Lundeen KA; Kohrumel JR; Pham NL; Brostoff SW; Bartholomew RM; Carlo DJ
    J Immunol; 1999 Jun; 162(12):7343-9. PubMed ID: 10358185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of bacillus Calmette-Guérin-activated macrophages to tumor targets. Selective inhibition by membrane preparations from homologous and heterologous neoplastic cells.
    Marino PA; Whisnant CC; Adams DO
    J Exp Med; 1981 Jul; 154(1):77-87. PubMed ID: 6788893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor cell threshold required for suppression of macrophage inflammation.
    Normann SJ
    J Natl Cancer Inst; 1978 May; 60(5):1091-6. PubMed ID: 417187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiation in murine mastocytoma induced by macrophage gangliosides.
    Schaade L; Thomssen R; Ritter K
    Z Naturforsch C J Biosci; 2000; 55(11-12):1004-10. PubMed ID: 11204177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxic T cell responses to a syngeneic tumour: conditions for primary activation in vitro.
    Warren HS; Woolnough JA; Lafferty KJ
    Aust J Exp Biol Med Sci; 1978 Apr; 56(2):247-51. PubMed ID: 98140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low response of BALB/c macrophages to priming and activating signals.
    Oswald IP; Afroun S; Bray D; Petit JF; Lemaire G
    J Leukoc Biol; 1992 Sep; 52(3):315-22. PubMed ID: 1381743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.